Inhibitors of proton-gated cation channels and their use in the treatment of ischaemic disorders
AssigneePainCeptor Pharma Corporation
InventorsThomas Varming, Frank Watjen
Life of this patent
Estimating the term…
Abstract
This invention relates to the use of compounds capable of inhibiting the activity of a proton-gated cation channel in the treatment of alleviation of diseases or disorders associated with, or mediated by a drop in extra cellular pH.
Claims30
Use of a compound capable of inhibiting a mammalian proton-gated cation channel for the manufacture of a medicament for the treatment, prevention or alleviation of a disease, disorder or condition associated with, or mediated by a drop in extracellular pH.
A method for the treatment, prevention or alleviation of a disease, disorder or condition in a subject, including a human, which disease, disorder or condition is associated with, or mediated by a drop in extracellular pH, said method comprising administering to the subject a pharmaceutically effective amount of a compound capable of inhibiting a mammalian proton-gated cation channel.
Dependencies are inferred from the claim text.